Clinical translation of liquid biopsy in early cancer screening: biofluid selection, model construction, and clinical validation.

Cui P, Xu S, Lin X, Song S, Huang B, Xu Z

Open source

DOI
10.3389/fonc.2026.1946352
Published
2026
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1946352,
  title = {Clinical translation of liquid biopsy in early cancer screening: biofluid selection, model construction, and clinical validation.},
  author = {Cui P and Xu S and Lin X and Song S and Huang B and Xu Z},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1946352},
  url = {https://doi.org/10.3389/fonc.2026.1946352}
}

RIS

TY  - JOUR
TI  - Clinical translation of liquid biopsy in early cancer screening: biofluid selection, model construction, and clinical validation.
AU  - Cui P
AU  - Xu S
AU  - Lin X
AU  - Song S
AU  - Huang B
AU  - Xu Z
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1946352
UR  - https://doi.org/10.3389/fonc.2026.1946352
ER  - 

APA

P, C., S, X., X, L., S, S., B, H., & Z, X. (2026). Clinical translation of liquid biopsy in early cancer screening: biofluid selection, model construction, and clinical validation.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1946352

Source records